This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Loma Linda University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: John F Wetteland: Innovator in Hemostatic Analysis
Introduction
John F Wetteland is a notable inventor based in Loma Linda, CA (US). He has made significant contributions to the field of hemostatic analysis through his innovative patent. His work focuses on improving the efficiency and automation of blood sample analysis, which is crucial for determining an individual's platelet function and coagulation status.
Latest Patents
Wetteland holds a patent for "Systems and methods for hemostatic analysis." This invention encompasses systems and methods for analyzing a whole blood sample to assess platelet function and coagulation status in a substantially automated manner. The patent also includes systems, reagent kits, and methods for the concurrent assessment of platelet function and coagulation as they interact during hemostasis. This innovation is vital for enhancing patient care and streamlining laboratory processes.
Career Highlights
Wetteland is affiliated with Loma Linda University, where he applies his expertise in hemostatic analysis. His work at the university allows him to collaborate with other professionals in the field and contribute to advancements in medical technology. His dedication to research and innovation has positioned him as a key figure in his area of expertise.
Collaborations
Wetteland has worked alongside notable colleagues, including Brian S Bull and Karen Hay. These collaborations have fostered a productive environment for research and development, leading to advancements in hemostatic analysis.
Conclusion
John F Wetteland's contributions to hemostatic analysis through his patent and work at Loma Linda University highlight his commitment to innovation in the medical field. His efforts continue to impact patient care positively and advance the understanding of blood coagulation processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
